C5a Antibodies

Santa Cruz Biotechnology offers a broad range of C5a Antibodies for research focused on understanding the complement system in immune responses. C5a Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C5a is a potent anaphylatoxin generated during complement activation, playing a critical role in inflammation and immune response regulation. When binding to C5aR, C5a triggers various cellular responses, including chemotaxis and immune cell activation. Research has shown that C5a significantly influences pathological conditions such as sepsis, autoimmune diseases, and chronic inflammatory disorders. Understanding C5a's molecular mechanisms and signaling pathways can lead to breakthroughs in therapeutic development. Investigating C5a's role in disease progression helps identify new treatment strategies for inflammatory conditions. C5a research continues to reveal important insights about immune system regulation and inflammatory responses. Santa Cruz Biotechnology monoclonal antibodies for C5a support researchers worldwide in advancing scientific understanding of immune system function and disease treatment.